Free Trial

Hims & Hers Health (HIMS) Competitors

Hims & Hers Health logo
$65.52 +5.25 (+8.71%)
Closing price 07/30/2025 03:59 PM Eastern
Extended Trading
$66.06 +0.54 (+0.82%)
As of 07/30/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HIMS vs. NTRA, FMS, GH, OPCH, RDNT, BTSG, SHC, SGRY, CON, and PRVA

Should you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Natera (NTRA), Fresenius Medical Care AG & Co. KGaA (FMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry.

Hims & Hers Health vs. Its Competitors

Hims & Hers Health (NYSE:HIMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk.

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 13.7% of Hims & Hers Health shares are held by insiders. Comparatively, 7.6% of Natera shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Hims & Hers Health currently has a consensus target price of $39.83, indicating a potential downside of 39.20%. Natera has a consensus target price of $183.76, indicating a potential upside of 30.37%. Given Natera's stronger consensus rating and higher possible upside, analysts plainly believe Natera is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
3 Sell rating(s)
8 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.92
Natera
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
1 Strong Buy rating(s)
3.06

Hims & Hers Health has a beta of 2.02, indicating that its stock price is 102% more volatile than the S&P 500. Comparatively, Natera has a beta of 1.73, indicating that its stock price is 73% more volatile than the S&P 500.

In the previous week, Hims & Hers Health had 43 more articles in the media than Natera. MarketBeat recorded 81 mentions for Hims & Hers Health and 38 mentions for Natera. Natera's average media sentiment score of 1.15 beat Hims & Hers Health's score of 0.37 indicating that Natera is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
20 Very Positive mention(s)
4 Positive mention(s)
50 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Neutral
Natera
21 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hims & Hers Health has higher earnings, but lower revenue than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$1.48B9.93$126.04M$0.6994.96
Natera$1.70B11.34-$190.43M-$1.47-95.89

Hims & Hers Health has a net margin of 9.24% compared to Natera's net margin of -10.36%. Hims & Hers Health's return on equity of 22.75% beat Natera's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health9.24% 22.75% 15.51%
Natera -10.36%-18.29%-11.68%

Summary

Hims & Hers Health beats Natera on 9 of the 17 factors compared between the two stocks.

Get Hims & Hers Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HIMS vs. The Competition

MetricHims & Hers HealthMEDICAL INFO SYS IndustryMedical SectorNYSE Exchange
Market Cap$13.49B$2.08B$5.63B$20.97B
Dividend YieldN/AN/A4.71%3.61%
P/E Ratio94.9637.9530.2028.76
Price / Sales9.9310.56455.8756.51
Price / Cash171.1455.7536.0123.15
Price / Book30.339.138.344.51
Net Income$126.04M-$63.64M$3.25B$993.26M
7 Day Performance14.38%-4.26%-2.15%-1.79%
1 Month Performance31.20%6.79%7.97%2.02%
1 Year Performance208.47%5.43%36.49%7.31%

Hims & Hers Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HIMS
Hims & Hers Health
2.1945 of 5 stars
$65.52
+8.7%
$39.83
-39.2%
+209.1%$13.49B$1.48B94.961,637Trending News
Upcoming Earnings
Analyst Downgrade
Insider Trade
NTRA
Natera
2.7885 of 5 stars
$140.61
+1.2%
$183.76
+30.7%
+44.2%$19.23B$1.70B-95.804,434Positive News
Analyst Upgrade
Insider Trade
FMS
Fresenius Medical Care AG & Co. KGaA
3.3529 of 5 stars
$25.86
-2.2%
$27.80
+7.5%
+31.4%$15.18B$19.49B23.091,384
GH
Guardant Health
3.9771 of 5 stars
$44.43
+0.0%
$54.45
+22.6%
+24.5%$5.51B$739.02M-13.112,021Trending News
OPCH
Option Care Health
4.6205 of 5 stars
$29.78
+0.3%
$35.50
+19.2%
-2.3%$4.88B$5.00B24.038,088News Coverage
Positive News
Gap Down
RDNT
RadNet
3.6944 of 5 stars
$57.72
+0.5%
$69.60
+20.6%
-5.0%$4.34B$1.83B-134.3611,021Positive News
BTSG
BrightSpring Health Services
1.8427 of 5 stars
$20.45
-0.4%
$24.90
+21.8%
+68.3%$3.59B$11.27B73.0235,000Upcoming Earnings
Gap Up
SHC
Sotera Health
2.9984 of 5 stars
$12.33
+0.2%
$16.00
+29.8%
-12.4%$3.50B$1.10B154.213,000Upcoming Earnings
SGRY
Surgery Partners
2.756 of 5 stars
$22.27
+4.7%
$33.33
+49.7%
-28.4%$2.85B$3.17B-14.5515,000Upcoming Earnings
Analyst Forecast
CON
Concentra Group Holdings Parent
3.121 of 5 stars
$19.93
+1.3%
$28.50
+43.0%
-12.0%$2.55B$1.93B14.8711,250Upcoming Earnings
PRVA
Privia Health Group
3.8511 of 5 stars
$19.74
+0.1%
$28.38
+43.8%
-6.8%$2.41B$1.74B164.441,140Positive News
Upcoming Earnings

Related Companies and Tools


This page (NYSE:HIMS) was last updated on 7/31/2025 by MarketBeat.com Staff
From Our Partners